Vestal Point Capital, LP - Mar 31, 2025 SCHEDULE 13G Report for Tyra Biosciences, Inc. Common Stock, par value $0.0001 per share (TYRA)

Filing Manager
Vestal Point Capital, LP
Reporting Manager
Vestal Point Capital, LP
Security
Tyra Biosciences, Inc. Common Stock, par value $0.0001 per share
Symbol
TYRA
Shares outstanding
53.3M shares
Disclosed Ownership
2.88M shares
Ownership
5.4%
Form type
SCHEDULE 13G
Date filed
5/15/2025, 04:14 PM
Date of event
Mar 31, 2025
SEC
View on sec.gov

Reporting Managers (2)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Vestal Point Capital, LP 5.4% 2.88M 0 2.88M /s/ Ryan Wilder By: Vestal Point Capital, LLC, General Partner, By: Ryan Wilder, Chief Investment Officer and Managing Partner
Ryan Wilder 5.4% 2.88M 0 2.88M /s/ Ryan Wilder Ryan Wilder, Individually